Photo from wikipedia
In recent years, longitudinal studies of Alzheimer's disease (AD) have been successively concluded. Our aim is to determine the efficacy of amyloid‐β (Aβ) PET in diagnosing AD and early prediction… Click to show full abstract
In recent years, longitudinal studies of Alzheimer's disease (AD) have been successively concluded. Our aim is to determine the efficacy of amyloid‐β (Aβ) PET in diagnosing AD and early prediction of mild cognitive impairment (MCI) converting to AD. By pooling studies from different centers to explore in‐depth whether diagnostic performance varies by population type, radiotracer type, and diagnostic approach, thus providing a more comprehensive theoretical basis for the subsequent widespread application of Aβ PET in the clinical setting.
Journal Title: Brain and Behavior
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!